Literature DB >> 28767343

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

Hugh Calkins1, Matias Nordaby2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28767343     DOI： 10.1056/NEJMc1707247

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  The use of cardiac-CT alone to exclude left atrial thrombus before atrial fibrillation ablation: Efficiency, safety, and cost analysis.

Authors:  Wassim Mosleh; Ali Sheikh; Zaid Said; Mohamed Abdel-Aal Ahmed; Siri Gadde; Tanvi Shah; Michael F Wilson; Hiroko Beck; Chee Kim; Umesh C Sharma
Journal:  Pacing Clin Electrophysiol       Date:  2018-06-04       Impact factor: 1.976

2.  Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation.

Authors:  Hammad Rahman; Safi U Khan; Michael DePersis; Tehseen Hammad; Fahad Nasir; Edo Kaluski
Journal:  Cardiovasc Revasc Med       Date:  2018-05-09

Review 3.  Reversal Agents in the Era of NOACs.

Authors:  Hany S Abed; Michael J Kilborn; Vivien Chen; Raymond W Sy
Journal:  J Atr Fibrillation       Date:  2017-12-31

4.  Benefits and Risks Associated with Long-term Oral Anticoagulation after Successful Atrial Fibrillation Catheter Ablation: Systematic Review and Meta-analysis.

Authors:  Kellina Maduray; Md Moneruzzaman; Geoffrey J Changwe; Jingquan Zhong
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.